![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12Q 1/68 | (2018.01) |
G01N 33/6893 | (2013.01) | ||
G01N 33/53 | (2006.01) | ||
G01N 33/721 | (2013.01) | ||
G01N 33/68 | (2006.01) | ||
G01N2333/51 | (2013.01) | ||
C07K 14/705 | (2006.01) | ||
A61K 38/179 | (2013.01) | ||
G01N 33/72 | (2006.01) | ||
C07K 14/71 | (2013.01) | ||
G01N 33/74 | (2006.01) | ||
A61P 7/06 | (2018.01) | ||
A61P 7/00 | (2018.01) | ||
C07K2319/30 | (2013.01) |
(11) | Number of the document | 3608419 |
(13) | Kind of document | T |
(96) | European patent application number | 19184182.4 |
Date of filing the European patent application | 2013-10-23 | |
(97) | Date of publication of the European application | 2020-02-12 |
(45) | Date of publication and mention of the grant of the patent | 2025-03-26 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
201261718126 P | 2012-10-24 | US |
(72) |
SUNG, Victoria , US
CHOPRA, Rajesh , GB
HERMINE, Olivier , FR
CRUZ MOURA, Ivan , FR
DUSSIOT, Michael , FR
TROVATI MACIEL, Thiago , FR
FRICOT, Aurelie , FR
|
(73) |
Celgene Corporation ,
Route 206 & Province Line Road, Princeton, NJ 08543,
US
|
(54) | BIOMARKER FOR USE IN TREATING ANEMIA |
BIOMARKER FOR USE IN TREATING ANEMIA |